Consultant Medical Devices Regulatory Affairs

Qserve Group is a specialized regulatory and quality consultancy that supports manufacturers and innovators in the medical device and in vitro diagnostic (IVD) sectors with regulatory strategy, conformity assessment, quality management, clinical evaluation, and market access. Operating as a professional services firm focused on the regulatory lifecycle of medical technologies, Qserve Group assists companies of varying sizes—from start-ups and small-medium enterprises to large multinational device manufacturers—by delivering technical and regulatory expertise intended to achieve and maintain market approval and compliance across multiple jurisdictions. The company’s publicly described scope centers on the intersection of regulatory affairs and quality systems for medical devices and diagnostics, with a portfolio of services designed to address pre-market requirements, notified body interactions and submissions, post-market obligations, and strategic global market entry. Core business activities of Qserve Group include regulatory strategy and submissions, preparation and review of technical documentation, quality management system (QMS) implementation and auditing, clinical evaluation and performance/clinical evidence generation, post-market surveillance and vigilance, and training and coaching for regulatory and quality professionals. In practical terms, the firm typically prepares or reviews regulatory technical documentation such as EU Technical Files and Design Dossiers, CE marking documentation under European legislation (including MDR and IVDR), and provides guidance and deliverables in support of conformity assessment processes with notified bodies. Qserve’s consultants commonly produce Clinical Evaluation Reports (CERs) and Performance Evaluation Reports (PERs), support clinical and usability study design and documentation, and develop post-market surveillance (PMS) and post-market clinical follow-up (PMCF) plans and reports, which are central to ongoing regulatory compliance in regulated medical technology markets. On the quality systems side, Qserve Group offers services to design, implement, and remediate QMS compliant with international standards such as ISO 13485. Typical engagements include gap analyses against regulatory requirements, development or revision of quality manuals and procedures, internal audit programs, supplier quality management, and pre-audit readiness for certification or notified body assessment. The firm also provides auditing services and support during regulatory inspections and notified body audits, helping clients address nonconformities and implement corrective and preventive actions (CAPA). Qserve’s service set extends to regulatory intelligence and strategic market access planning. Consultants help clients determine product classification, applicable regulatory pathways and standards, and regulatory strategy tailored to target markets—most frequently the European Union, the United States, and other major medical device markets. For companies seeking entry into the U.S., the firm supports preparation of FDA submissions such as 510(k) premarket notifications and other regulatory dossiers. For EU market access, Qserve assists with preparation of documentation required by the Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR), and supports interaction and communication with notified bodies. The company also addresses region-specific requirements such as registration and local representation where needed. Recognizing the growing role of software and cybersecurity in medical technologies, Qserve provides specialized support for software as a medical device (SaMD), mobile health applications, and cybersecurity risk management. These services typically include conformity assessment advice specific to software, preparation of technical documentation for software products, support for clinical evaluation of software functions, and development of cybersecurity risk management files and vulnerability management processes aligned with applicable guidance and standards. Qserve Group also emphasizes training services and capacity-building for client organizations. Typical training offerings are focused on regulatory requirements, QMS implementation, clinical evaluation and post-market surveillance, and MDR/IVDR transition topics. Training is delivered in formats ranging from public workshops and webinars to bespoke in-house programs designed for engineering, clinical, regulatory affairs, and quality teams. In addition to direct client engagements, Qserve’s publicly presented capabilities include services that help firms manage interactions with third parties involved in device commercialization—such as notified bodies, clinical sites, and suppliers. The firm’s consultants provide representation and project-management support during conformity assessment procedures, help to structure technical documentation for efficient review, and assist with regulatory correspondence and responses to questions from regulators or notified bodies. Overall, Qserve Group positions itself as a specialized partner for organizations navigating the complex regulatory and quality landscape of medical devices and diagnostics. The company’s offerings span the full product lifecycle—from initial classification and regulatory strategy, through pre-market technical and clinical evidence generation, to post-market surveillance and ongoing compliance—aiming to reduce time-to-market risk and improve regulatory readiness. While the firm’s public materials focus primarily on medical device and IVD regulatory and quality services, this work inherently supports technology development and commercialization in medtech, including hardware, diagnostics, and software-driven products.